Skip to main content

GOLDMAN SACHS GROUP INC

Position in ABUS — Arbutus Biopharma Corp

CIK 886982 NEW YORK, NY

Position in ABUS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,832,648
+$11,880,696 QoQ
Shares Held
3,506,802
+218.7% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 1% None 3%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ABUS ranks #127 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABUS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,832,648 3,506,802
2026-03-31 $4,951,952 1,100,434
2025-12-31 $3,552,569 738,580
2025-09-30 $9,867,371 2,173,430
2025-06-30 $9,392,929 3,039,783
2025-03-31 $7,245,058 2,075,948
2024-12-31 $1,739,240 531,878
2024-09-30 $2,157,566 560,407
2024-06-30 $486,145 157,329
2024-03-31 $450,738 174,705
2023-12-31 $316,475 126,590
2023-09-30 $415,416 204,639
2023-06-30 $510,866 222,116
2023-03-31 $819,896 270,593
2022-12-31 $894,651 383,971
2022-09-30 $1,243,478 651,036
2022-06-30 $1,981,456 731,165
2022-03-31 $4,592,731 1,541,185
2021-12-31 $2,696,823 693,271
2021-09-30 $1,229,668 286,636
2021-06-30 $316,586 104,484
2021-03-31 $148,647 44,639
2020-12-31 $210,337 59,250
2020-09-30 $795,379 254,115
2020-06-30 $3,029,082 1,664,331
2020-03-31 $1,957,712 1,938,329